Recent Finacing
Recent Raise
Ambagon Therapeutics develops molecular-glue stabilizers that selectively stabilize 14-3-3:client interactions, combining structural insights, curated chemistry, high-throughput X-ray crystallography, and bespoke functional assays for oncology programs.
